XML 53 R6.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)
$ in Millions
Common Stock
Management Units
Treasury Stock at Cost
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Total
Balances at beginning of period at Dec. 31, 2016 $ 0.7     $ (58.8)   $ (617.9) $ (676.0)
Balances at beginning of period (in shares) at Dec. 31, 2016 66,498,762 201,696          
Increase (Decrease) in Stockholders' Deficit              
Repurchase of old management units       (8.8)     (8.8)
Cancellation of management D units (in units)   (201,696)          
Proceeds from issuance of common stock, net of issue costs $ 0.2     333.9     334.1
Proceeds from issuance of common stock, net of issue costs (in shares) 20,970,589            
Contribution from Parent       20.3     20.3
Non-cash compensation expense       13.4     13.4
Issuance of restricted stock, net (in shares) 1,418,564            
Purchase of shares     $ (4.8)       $ (4.8)
Purchase of shares (in shares) (461,173)           (461,173)
Other       (0.1)     $ (0.1)
Net income (loss)           185.3 185.3
Balances at end of period at Dec. 31, 2017 $ 0.9   (4.8) 299.9   (432.6) (136.6)
Balances at end of period (in shares) at Dec. 31, 2017 88,426,742            
Increase (Decrease) in Stockholders' Deficit              
Impact of change in accounting policy           9.1 9.1
Changes in accumulated other comprehensive loss, net         $ (6.5)   (6.5)
Stock-based compensation       13.0     13.0
Issuance of restricted stock, net (in shares) 1,684,778            
Purchase of shares     (73.3)       $ (73.3)
Purchase of shares (in shares) (7,431,140)           (7,431,140)
Other       (0.2)     $ (0.2)
Net income (loss)           (87.3) (87.3)
Balances at end of period at Dec. 31, 2018 $ 0.9   (78.1) 312.7 (6.5) (510.8) $ (281.8)
Balances at end of period (in shares) at Dec. 31, 2018 82,680,380           82,680,380
Increase (Decrease) in Stockholders' Deficit              
Changes in accumulated other comprehensive loss, net         (9.0)   $ (9.0)
Stock-based compensation       10.1     10.1
Issuance of restricted stock, net (in shares) 1,609,514            
Purchase of shares     (1.6)       $ (1.6)
Purchase of shares (in shares) (186,786)           (186,786)
Net income (loss)           36.4 $ 36.4
Balances at end of period at Dec. 31, 2019 $ 0.9   $ (79.7) $ 322.8 $ (15.5) $ (474.4) $ (245.9)
Balances at end of period (in shares) at Dec. 31, 2019 84,103,108           84,103,108